Risk Factor    Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus Am J Cardiol (2008) 101; 596-601 X. Yang, W. Y. So, A. P. Kong, R. C. Ma, G. T. Ko, C. S. Ho, C. W. Lam, C. S. Cockram, J. C. Chan and P. C. Tong Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice Am J Cardiol (2008) 101; 919-24 R. T. Yan, A. T. Yan, C. B. Granger, J. Lopez-Sendon, D. Brieger, B. Kennelly, A. Budaj, P. G. Steg, A. A. Georgescu, Q. Hassan and S. G. Goodman Drug-eluting stents in octogenarians: early and intermediate outcome Am Heart J (2008) 155; 680-6 P. J. Vlaar, R. J. Lennon, C. S. Rihal, M. Singh, H. H. Ting, J. F. Bresnahan and D. R. Holmes, Jr Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography Am J Cardiol (2008) 102; 1451-6 R. Venkataraman, F. G. Hage, T. Dorfman, J. Heo, R. A. Aqel, A. M. de Mattos and A. E. Iskandrian Impact on contrast, fluoroscopy, and catheter utilization from knowing the coronary artery bypass graft anatomy before diagnostic coronary angiography Am J Cardiol (2008) 101; 1729-32 I. Varghese, D. M. Boatman, C. T. Peters, J. Daye, A. Haider, M. Roesle, S. Banerjee and E. S. Brilakis Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease Am J Cardiol (2008) 102; 192-6 Y. R. van Gestel, S. E. Hoeks, D. D. Sin, C. Simsek, G. M. Welten, O. Schouten, H. Stam, F. W. Mertens, R. T. van Domburg and D. Poldermans Three life-years gained from smoking cessation after coronary artery bypass surgery: a 30-year follow-up study Am Heart J (2008) 156; 473-6 R. T. van Domburg, W. S. op Reimer, S. E. Hoeks, A. P. Kappetein and A. J. Bogers Cardiovascular disease and risk factors in Asia: a selected review Circulation (2008) 118; 2702-9 H. Ueshima, A. Sekikawa, K. Miura, T. C. Turin, N. Takashima, Y. Kita, M. Watanabe, A. Kadota, N. Okuda, T. Kadowaki, Y. Nakamura and T. Okamura Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study Circulation (2009) 119; 1711-9 S. Tsimikas, P. Clopton, E. S. Brilakis, S. M. Marcovina, A. Khera, E. R. Miller, J. A. de Lemos and J. L. Witztum Missed opportunities for reperfusion therapy for ST-segment elevation myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) study Am Heart J (2008) 155; 471-7 A. J. Tricomi, D. J. Magid, J. S. Rumsfeld, D. R. Vinson, E. E. Lyons, L. Crounse, P. M. Ho, P. N. Peterson and F. A. Masoudi Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes Am Heart J (2009) 157; 740-5 H. Tizon-Marcos, O. F. Bertrand, J. Rodes-Cabau, E. Larose, V. Gaudreault, R. Bagur, O. Gleeton, J. Courtis, L. Roy, P. Poirier, O. Costerousse and R. De Larochelliere Usefulness of persistent symptoms of depression to predict physical health status 12 months after an acute coronary syndrome Am J Cardiol (2008) 101; 15-9 B. D. Thombs, R. C. Ziegelstein, D. E. Stewart, S. E. Abbey, K. Parakh and S. L. Grace Eighteen year (1985-2002) analysis of incidence, mortality, and cardiac procedure outcomes of acute myocardial infarction in patients > or = 65 years of age Am J Cardiol (2008) 101; 930-6 S. M. Tahir, L. L. Price, P. B. Shah and F. G. Welt Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Circulation (2008) 117; 2104-13 S. D. Solomon, J. Wittes, P. V. Finn, R. Fowler, J. Viner, M. M. Bertagnolli, N. Arber, B. Levin, C. L. Meinert, B. Martin, J. L. Pater, P. E. Goss, P. Lance, S. Obara, E. Y. Chew, J. Kim, G. Arndt and E. Hawk Comparison of usefulness of C-reactive protein versus white blood cell count to predict outcome after primary percutaneous coronary intervention for ST elevation myocardial infarction Am J Cardiol (2008) 101; 446-51 J. J. Smit, J. P. Ottervanger, R. J. Slingerland, J. J. Kolkman, H. Suryapranata, J. C. Hoorntje, J. H. Dambrink, A. T. Gosselink, M. J. de Boer, F. Zijlstra and A. W. van 't Hof Effect of prehospital triage on revascularization times, left ventricular function, and survival in patients with ST-elevation myocardial infarction Am J Cardiol (2009) 103; 907-12 G. Sivagangabalan, A. T. Ong, A. Narayan, N. Sadick, P. S. Hansen, G. C. Nelson, M. Flynn, D. L. Ross, S. C. Boyages and P. Kovoor Usefulness of fasting plasma glucose to predict mortality or coronary heart disease in persons > or = 60 years of age without diabetes mellitus or in those with undiagnosed diabetes mellitus (from The Dubbo Study) Am J Cardiol (2008) 102; 831-4 L. A. Simons, J. Simons, Y. Friedlander and J. McCallum Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease Am J Cardiol (2008) 101; 1741-6 M. H. Shishehbor, L. P. Oliveira, M. S. Lauer, D. L. Sprecher, K. Wolski, L. Cho, B. J. Hoogwerf and S. L. Hazen Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age Am J Cardiol (2008) 101; 1531-6 S. Setoguchi, D. H. Solomon, R. Levin and W. C. Winkelmayer Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study) Am J Cardiol (2009) 103; 897-901 O. Schouten, J. P. van Kuijk, W. J. Flu, T. A. Winkel, G. M. Welten, E. Boersma, H. J. Verhagen, J. J. Bax and D. Poldermans Contact-to-balloon time and door-to-balloon time after initiation of a formalized data feedback in patients with acute ST-elevation myocardial infarction Am J Cardiol (2008) 101; 46-52 K. H. Scholz, R. Hilgers, D. Ahlersmann, H. Duwald, R. Nitsche, G. von Knobelsdorff, B. Volger, K. Moller and F. K. Keating Relation of cardiac troponin I levels with in-hospital mortality in patients with ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage Am J Cardiol (2008) 102; 632-4 R. Sandhu, W. S. Aronow, A. Rajdev, R. Sukhija, H. Amin, K. D'Aquila and A. Sangha Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women J Am Coll Cardiol (2008) 51; 997-1002 R. Rossi, A. Nuzzo, G. Origliani and M. G. Modena Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study Circulation (2008) 117; 605-13 G. A. Rosito, J. M. Massaro, U. Hoffmann, F. L. Ruberg, A. A. Mahabadi, R. S. Vasan, C. J. O'Donnell and C. S. Fox Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials) Am J Cardiol (2008) 102; 693-9 J. G. Robinson, R. Wallace, M. Limacher, H. Ren, B. Cochrane, S. Wassertheil-Smoller, J. K. Ockene, P. L. Blanchette and M. G. Ko Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events Am Heart J (2008) 155; 654-60 M. J. Rinaldi, A. J. Kirtane, R. N. Piana, R. P. Caputo, P. C. Gordon, J. J. Lopez, H. L. Dauerman, T. J. Ryan, Jr., F. J. Kiernan, D. E. Cutlip, K. K. Ho, C. M. Gibson, S. A. Murphy and D. J. Cohen A Pilot Study To Examine the Effects of Smoking Cessation on Serum Markers of Inflammation in Women at Risk for Cardiovascular Disease Chest (2009) V. Reichert, X. Xue, D. Bartscherer, D. Jacobsen, C. Fardellone, P. Folan, N. Kohn, A. Talwar and C. N. Metz The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years Am J Cardiol (2008) 102; 1668-73 A. Rashidi, A. R. Sehgal, M. Rahman and A. S. O'Connor Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians Am J Cardiol (2008) 102; 1663-7 C. Rahilly-Tierney, T. S. Bowman, L. Djousse, H. D. Sesso and J. M. Gaziano Coronary artery calcium to predict all-cause mortality in elderly men and women J Am Coll Cardiol (2008) 52; 17-23 P. Raggi, M. C. Gongora, A. Gopal, T. Q. Callister, M. Budoff and L. J. Shaw Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus Am Heart J (2008) 155; 284-9 A. Porter, A. R. Assali, A. Zahalka, Z. Iakobishvili, D. Brosh, E. I. Lev, A. Mager, A. Battler, R. Kornowski and D. Hasdai Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study) Am J Cardiol (2008) 101; 303-7 D. S. Pinto, A. J. Kirtane, Y. B. Pride, S. A. Murphy, M. S. Sabatine, C. P. Cannon and C. M. Gibson Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial Am Heart J (2008) 155; 388-94 G. Pedrazzini, E. Santoro, R. Latini, L. Fromm, M. G. Franzosi, T. Mocetti, L. Staszewsky, S. Barlera, G. Tognoni and A. P. Maggioni Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus Am J Cardiol (2008) 102; 1328-34 G. Patti, A. Nusca and G. Di Sciascio Disparities in use of same-day percutaneous coronary intervention for patients with ST-elevation myocardial infarction in Florida, 2001-2005 Am J Cardiol (2008) 102; 802-8 E. B. Pathak and J. A. Strom Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study) Am J Cardiol (2008) 102; 47-53 N. I. Parikh, S. J. Hwang, M. G. Larson, D. Levy and C. S. Fox Impact of renal insufficiency on angiographic, procedural, and in-hospital outcomes following percutaneous coronary intervention Am J Cardiol (2008) 101; 780-5 M. D. Osten, J. Ivanov, J. Eichhofer, P. H. Seidelin, J. R. Ross, A. Barolet, E. M. Horlick, D. Ing, L. Schwartz, K. Mackie and V. Dzavik Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome in patients with acute coronary syndrome Am J Cardiol (2009) 103; 791-5 H. Okura, Y. Kobayashi, S. Sumitsuji, M. Terashima, T. Kataoka, M. Masutani, M. Ohyanagi, K. Shimada, H. Taguchi, Y. Yasuga, Y. Takeda, Y. Ohashi, K. Awano, K. Fujii and G. S. Mintz Comparison of intravascular ultrasound to contrast-enhanced 64-slice computed tomography to assess the significance of angiographically ambiguous coronary narrowings Am J Cardiol (2008) 102; 994-1001 T. Okabe, W. G. Weigold, G. S. Mintz, R. Roswell, S. Joshi, S. Y. Lee, B. Lee, D. H. Steinberg, P. Roy, T. L. Slottow, K. Smith, R. Torguson, Z. Xue, L. F. Satler, K. M. Kent, A. D. Pichard, N. J. Weissman, J. Lindsay and R. Waksman Gender disparity in cardiac procedures and medication use for acute myocardial infarction Am Heart J (2008) 155; 862-8 J. T. Nguyen, A. K. Berger, S. Duval and R. V. Luepker Hematologic parameters, atherosclerotic progression, and prognosis in patients with previous coronary artery bypass grafting (from the Post CABG Trial) Am J Cardiol (2009) 103; 328-32 K. J. Mukamal, G. A. Wellenius and M. A. Mittleman Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease Circulation (2008) 117; 3031-8 D. Mozaffarian, P. W. Wilson and W. B. Kannel Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events Circulation (2008) 118; 993-1001 S. Mora, N. Rifai, J. E. Buring and P. M. Ridker Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome Am Heart J (2008) 155; 725-31 L. M. Mielniczuk, M. A. Pfeffer, E. F. Lewis, M. A. Blazing, J. A. de Lemos, A. Shui, S. Mohanavelu, R. M. Califf and E. Braunwald Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial) Am J Cardiol (2008) 102; 1151-5 N. Mercado, J. J. Brugts, J. H. Ix, M. G. Shlipak, S. R. Dixon, B. J. Gersh, P. A. Lemos, M. Guarneri, P. S. Teirstein, W. Wijns, P. W. Serruys, E. Boersma and W. W. O'Neill Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions Jr. Am Heart J (2008) 156; 728-35 R. H. Mehta, E. Honeycutt, L. K. Shaw and M. H. Sketch Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality Am Heart J (2008) 156; 277-83 P. A. McCullough, S. Li, C. T. Jurkovitz, L. Stevens, A. J. Collins, S. C. Chen, K. C. Norris, S. McFarlane, B. Johnson, M. G. Shlipak, C. I. Obialo, W. W. Brown, J. Vassalotti, A. T. Whaley-Connell, R. M. Brenner and G. L. Bakris Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study) Am J Cardiol (2008) 101; 1560-6 A. Maresta, E. Varani, M. Balducelli, F. Varbella, C. Lettieri, L. Uguccioni, P. Sangiorgio and G. B. Zoccai Impact of chronic kidney disease on major bleeding complications and mortality in patients with indication for oral anticoagulation undergoing coronary stenting Chest (2009) 135; 983-90 S. Manzano-Fernandez, F. Marin, F. J. Pastor-Perez, C. Caro, F. Cambronero, J. Lacunza, E. Pinar, D. A. Pascual-Figal, M. Valdes and G. Y. Lip Performance of cavopulmonary palliation at elevated altitude: midterm outcomes and risk factors for failure Circulation (2008) 118; S177-81 S. P. Malhotra, D. D. Ivy, M. B. Mitchell, D. N. Campbell, M. L. Dines, S. Miyamoto, J. Kay, D. R. Clarke and F. Lacour-Gayet Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study Am Heart J (2009) 157; 658-65 K. H. Mak, D. L. Bhatt, M. Shao, G. J. Hankey, J. D. Easton, K. A. Fox and E. J. Topol Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol (2008) 102; 6-11 E. I. Lev, R. Kornowski, H. Vaknin-Assa, A. Porter, I. Teplitsky, I. Ben-Dor, D. Brosh, S. Fuchs, A. Battler and A. Assali Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome Am Heart J (2008) 156; 177-84 S. Leung, D. Gallup, K. W. Mahaffey, M. Cohen, E. M. Antman, S. G. Goodman, R. A. Harrington, A. Langer, P. Aylward, J. J. Ferguson and R. M. Califf Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population Circulation (2008) 118; 2672-8 . Kubo, J. Hata, Y. Doi, Y. Tanizaki, M. Iida and Y. Kiyohara Combined prognostic utility of white blood cell count, plasma glucose, and glomerular filtration rate in patients undergoing primary stent placement for acute myocardial infarction Am J Cardiol (2009) 103; 322-7 M. Kosuge, K. Kimura, S. Morita, S. Kojima, T. Sakamoto, M. Ishihara, Y. Asada, C. Tei, S. Miyazaki, M. Sonoda, K. Tsuchihashi, M. Yamagishi, M. Shirai, H. Hiraoka, T. Honda, Y. Ogata and H. Ogawa Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II) Am J Cardiol (2008) 101; 1550-9 A. A. Khattab, J. Daemen, G. Richardt, P. Rioux, F. W. Amann, R. Levy, I. G. Horvath, R. C. Teles, F. Ordoubadi, M. Pieters, K. Wittebols, H. P. Stoll and P. W. Serruys Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment Eur Heart J (2008) 29; 1001-10 P. P. Karjalainen, S. Vikman, M. Niemela, P. Porela, A. Ylitalo, M. A. Vaittinen, M. Puurunen, T. J. Airaksinen, K. Nyman, T. Vahlberg and K. E. Airaksinen Perinatal risk factors for ischemic heart disease: disentangling the roles of birth weight and preterm birth Circulation (2008) 117; 405-10 M. Kaijser, A. K. Bonamy, O. Akre, S. Cnattingius, F. Granath, M. Norman and A. Ekbom Comparison of intravascular ultrasound and angiographic assessment of coronary reference segment size in patients with type 2 diabetes mellitus Am J Cardiol (2008) 101; 590-5 L. O. Jensen, P. Thayssen, G. S. Mintz, R. Egede, M. Maeng, A. Junker, A. Galloee, E. H. Christiansen, K. E. Pedersen, H. S. Hansen and K. N. Hansen Relation of a coronary artery calcium score higher than 400 to coronary stenoses detected using multidetector computed tomography and to traditional cardiovascular risk factors Am J Cardiol (2008) 101; 1444-7 . S. Ho, S. J. Fitzgerald, L. L. Stolfus, W. A. Wade, D. B. Reinhardt, C. E. Barlow and J. J. Cannaday Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus Am J Cardiol (2009) 103; 772-8 T. Hasin, M. Hochadel, A. K. Gitt, S. Behar, H. Bueno and Y. Hasin How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study Circulation (2008) 117; 598-604 S. L. Hardoon, P. H. Whincup, L. T. Lennon, S. G. Wannamethee, S. Capewell and R. W. Morris Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors Circulation (2008) 118; e20-8 C. Grunfeld, D. P. Kotler, D. K. Arnett, J. M. Falutz, S. M. Haffner, P. Hruz, H. Masur, J. B. Meigs, K. Mulligan, P. Reiss and K. Samaras Glucose levels compared with diabetes history in the risk assessment of patients with acute myocardial infarction Am Heart J (2009) 157; 763-70 A. Goyal, S. R. Mehta, H. C. Gerstein, R. Diaz, R. Afzal, D. Xavier, J. Zhu, P. Pais, L. Lisheng, K. A. Kazmi, M. Zubaid, L. S. Piegas, P. Widimsky, A. Budaj, A. Avezum and S. Yusuf Angina pectoris and atherosclerotic risk factors in the multisite cardiac lifestyle intervention program Am J Cardiol (2008) 101; 911-8 J. Frattaroli, G. Weidner, T. A. Merritt-Worden, S. Frenda and D. Ornish Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo Am Heart J (2009) 157; 383 e1-8 A. V. Finn, J. S. Oh, M. Hendricks, M. Daher, E. Cagliero, R. M. Byrne, J. Nadelson, J. Crimins, A. Kastrati, A. Schomig, O. Bruskina, I. Palacios, M. C. John and H. K. Gold Risk factor management after myocardial infarction: reported adherence and outcomes Am Heart J (2009) 157; 556-62 C. Decker, H. Ahmad, K. L. Moreng, T. M. Maddox, K. J. Reid, P. G. Jones and J. A. Spertus Presence and extent of coronary artery disease by cardiac computed tomography and risk for acute coronary syndrome in cocaine users among patients with chest pain Am J Cardiol (2009) 103; 620-5 F. Bamberg, C. L. Schlett, Q. A. Truong, I. S. Rogers, W. Koenig, J. T. Nagurney, S. Seneviratne, S. J. Lehman, R. C. Cury, S. Abbara, J. Butler, H. Lee, T. J. Brady and U. Hoffmann Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials) Am J Cardiol (2008) 102; 1009-16 J. Aoki, G. S. Mintz, N. J. Weissman, L. Mandinov, E. Grube, K. D. Dawkins, S. G. Ellis, J. Greenberg, A. Yu, J. T. Mann, L. Cannon, P. A. Cambier and G. W. Stone